What is Source Molecular?
Source Molecular operates as a specialized provider of enterprise-level IT solutions, with a core competency in Anaplan modeling and bespoke software development. With over two decades of industry experience, the company has established itself as a critical partner for organizations seeking to optimize their internal business processes. Their team of seasoned IT professionals focuses on creating tailored technological frameworks that drive operational efficiency and long-term business success. By maintaining a strong presence in the technology sector, Source Molecular bridges the gap between complex data modeling and actionable business intelligence, ensuring that clients can navigate digital transformation with precision and reliability.
How much funding has Source Molecular raised?
Source Molecular has raised a total of $1.6M across 1 funding round:
Series A
$1.6M
Series A (2017): $1.6M with participation from New World Angels
Key Investors in Source Molecular
New World Angels
New World Angels is a Florida-based group of angel investors and venture capitalists that provides seed funding and guidance to qualified early-stage companies. They aim to support entrepreneurs from diverse backgrounds and cultures, focusing on startups that can create significant market impact.
What's next for Source Molecular?
Looking ahead, the recent strategic investment is expected to catalyze Source Molecular's expansion into new market segments and accelerate the development of its proprietary software offerings. The company is likely to prioritize the enhancement of its Anaplan modeling practice, a high-growth area that remains essential for modern enterprise planning and financial forecasting. Furthermore, the capital will likely support the acquisition of top-tier technical talent and the refinement of their service delivery models to meet the evolving needs of a global client base. As the firm enters this next phase of growth, the focus will remain on maintaining the high standards of quality that have defined its two-decade tenure in the IT services industry, ultimately aiming to capture a larger share of the enterprise software market.
See full Source Molecular company page
